Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × nirogacestat × 30 days × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 93 Magnetic Resonance Spectroscopy 70 Biopsy 62 pembrolizumab 60 Cyclophosphamide 55 fludarabine 39 Carboplatin 30 Nivolumab 29 Gemcitabine 28 Cisplatin 26 Paclitaxel 22 fludarabine phosphate 20 atezolizumab 20 Bevacizumab 19 Radiotherapy 18 Ipilimumab 18 venetoclax 17 Fluorouracil 16 X-Rays 15 Oxaliplatin 14 Dexamethasone 14 Cetuximab 14 Taxes 13 Lenalidomide 13 Rituximab 12 Radiotherapy, Intensity-Modulated 11 Leucovorin 11 Injections 11 Doxorubicin 11 Decitabine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04722146 2026-04-13

MajesTEC-2

Janssen Research & Development, LLC

Phase 1 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡